aspirin has been researched along with acenocoumarol in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (18.52) | 18.7374 |
1990's | 11 (20.37) | 18.2507 |
2000's | 15 (27.78) | 29.6817 |
2010's | 16 (29.63) | 24.3611 |
2020's | 2 (3.70) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Altman, R; Boullon, F; de la Fuente, L; Favaloro, R; Raca, R; Rouvier, J | 1 |
Kakkar, VV | 1 |
Altman, R; D'Ortencio, O; de La Fuente, L; Favaloro, RG; Gurfinkel, E; Manzanel, R; Rouvier, J | 1 |
Stern, D; Vasey, H | 1 |
Boda, Z; Hársfalvi, J; Pfliegler, G; Tornai, I; Udvardy, M; Voith, L | 1 |
Berri, G; Kreutzer, G; Lazzari, MA; Meschengieser, S; Vargas, J; Woods, A | 1 |
Ardelt, W; Bolze, H; Dittrich, A | 1 |
Bechar, M; Beks, JW; Lakke, JP; Penning, L; van der Hem, GK | 1 |
Florkiewicz, H; Markiewicz, M; Rymar, B; Wysokiński, A | 1 |
Kraska, T; Malanowicz, W; Skarzyńska, M; Tymińska, K | 1 |
Albertal, J; Carreras, LO; Lazzari, MA; Pavlosky, M | 1 |
Farkas, A; Sámóczi, M; Sipos, E; Tarján, J | 1 |
Brutel de la Rivière, A; Dunselman, PH; Hillege, HL; Kootstra, GJ; Lie, KI; Mulder, BJ; Pfisterer, M; van der Meer, J; van Gilst, WH | 1 |
Dunning, AJ; Mulder, BJ; Piek, JJ; Tijssen, JG; van der Doef, RM; van der Meer, J; van der Wall, EE | 1 |
Ascoop, CA; Hillege, HL; Kootstra, GJ; Lie, KI; Mulder, BJ; Pfisterer, M; van der Meer, J; van Gilst, WH | 1 |
Albertal, J; Aramburu, DF; Diaz, R; Lardani, H; Pereyra, D; Segura, EV; Sutton, M | 1 |
Cleophas, TJ; Niemeyer, MG; Tavenier, P | 1 |
Aulesa, C; Ortega, JJ; Petit, M; Sentis, M | 1 |
Agustí, A; Arnau, JM; Ferrer, A; Laporte, JR; Llop, R; Vidal, X | 1 |
Azaceta, G; Civeira, E; Cornudella, R; Iturbe, T; Moreno, JA; Olave, T; Peleato, J; Sánchez, C; Varo, MJ | 1 |
Antón, JJ; Brotons, C; Cobos, M; Cucurull, E; Gállego, C; Ibáñez, M; Llussà, J; López, A; Moral, I; Orozco, P; Pérez, A; Permanyer, G; Samarra, M; Sanz, J; Ventureira, S | 1 |
Alexopoulos, D; Cokkinos, D; Fakiolas, C; Foussas, S; Hatzimiltiadis, S; Louridas, G; Olympios, C; Pavlides, G; Pissimisis, E; Sionis, D; Stefanadis, C; Stefanidis, A; Toutouzas, P; Vavouranakis, E; Vitakis, S; Voudris, V; Vrahatis, A; Zairis, M | 1 |
Algra, A; Eikelboom, BC; Hennekes, S; Lawson, JA; Tangelder, MJ | 1 |
Carerj, S; Di Perri, R; Epifanio, A; Gallitto, G; Gangemi, S; Granata, A; La Spina, P; Leggiadro, N; Manganaro, A; Musolino, R; Tripodi, F | 1 |
Antretter, H; Fries, D; Hörmann, C; Innerhofer, P; Margreiter, J; Schobersberger, W; Streif, W | 1 |
Falk, RH | 1 |
Gudín-Uriel, M; Ridocci-Soriano, F; Sánchez-Torrijos, J | 1 |
Anand, S; Budaj, A; Cina, C; Crowell, R; Eikelboom, J; Gosselin, G; Guzman, R; Keltai, M; Liu, L; Pogue, J; Sussex, B; Xie, C; Yusuf, S | 1 |
Alonso Santor, JE; Inglada Galiana, L; Pérez Paredes, G | 1 |
Jakubczyk, M; Jakubczyk, P; Popławski, C | 1 |
Ataullakhanova, DM; Bykova, ES; Dobrovol'skiĭ, AB; Kropacheva, ES; Panchenko, EP; Titaeva, EV; Zharkova, TV | 1 |
Gasior, M; Kaczmarski, J; Kuliczkowski, W; Poloński, L; Zembala, M | 1 |
Escarment, J; Lions, C; Ould-Ahmed, M; Petitjeans, F; Wey, PF | 1 |
Alonso, A; Hermida, J; Montes, R; Nantes, O; Zozaya, JM | 1 |
de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC | 1 |
Bartels, RH; Nandoe Tewarie, RD | 1 |
Hillege, HL; van der Meer, J; Veeger, NJ; Zijlstra, F | 1 |
Hiratzka, LF | 1 |
Bron, AM; Creuzot-Garcher, C; Juniot, A; Koehrer, P; Passemard, M | 1 |
Hoffman, P; Kowalski, M; Michałowska, I; Rybicka, J | 1 |
Bajkin, BV; Bajkin, IA; Petrovic, BB | 1 |
Bagratuni, T; Dimopoulos, MA; Eleutherakis-Papaiakovou, E; Gavriatopoulou, M; Kanelias, N; Kastritis, E; Kostouros, E; Politou, M; Roussou, M; Terpos, E | 1 |
Anitua, E; Orive, G; Troya, M; Zalduendo, MM | 1 |
Jarmak, A; Jończyk-Skórka, K; Kowalski, J; Śliwczyńska-Rodziewicz, D | 1 |
Huisman, MV; Jansen, EK; Keijzers, M; Schotten, J; Umans, VA; van der Wall, SJ; Vonk, AB; Wolterbeek, R | 1 |
Dogné, JM; Sennesael, AL; Spinewine, A | 1 |
Bouziana, SD; Dourliou, V; Giampatzis, V; Hatzitolios, AI; Kostaki, S; Papadopoulou, M; Savopoulos, C; Sofogianni, A; Spanou, M; Tziomalos, K | 1 |
Fahed, E; Ghauche, J; Maarrawi, J; Menassa-Moussa, L; Moussa, R; Nohra, G; Okais, N; Rahme, R; Rizk, T; Samaha, E | 1 |
Chouliaras, C; Kouraklis, G; Liagkos, G; Spyropoulos, C; Tsourouflis, G; Vagianos, CE | 1 |
Arnold, M; Bonati, LH; Brehm, A; Bruni, N; Christensen, H; De Marchis, GM; Engelter, ST; Feil, K; Fischer, U; Gensicke, H; Gralla, J; Hamann, J; Jung, S; Kägi, G; Kahles, T; Kellert, L; Leib, SL; Luft, AR; Lyrer, P; Michel, P; Nedeltchev, K; Nolte, CH; Peters, N; Polymeris, AA; Psychogios, MN; Rosenbaum, S; Schaedelin, SA; Seiffge, D; Simonetti, BG; Sirimarco, G; Steiner, L; Stippich, C; Sztajzel, R; Traenka, C; Vehoff, J; von Rennenberg, R; Wegener, S | 1 |
Erika, MH; Jaime, GC; Maximiliano, CL | 1 |
3 review(s) available for aspirin and acenocoumarol
Article | Year |
---|---|
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Humans; Injections, Subcutaneous; Middle Aged; Postoperative Complications; Thrombophlebitis; United Kingdom | 1975 |
[The antiphospholipid syndrome, an update].
Topics: Abortion, Spontaneous; Acenocoumarol; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enzyme-Linked Immunosorbent Assay; Female; Fibrinolytic Agents; Heparin; Humans; Lupus Coagulation Inhibitor; Male; Platelet Aggregation Inhibitors; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombophilia; Thrombosis; Warfarin | 2007 |
[Monitoring of antiplatelet drug effects--fashion or necessity?].
Topics: Acenocoumarol; Aspirin; Blood Platelets; Clopidogrel; Drug Monitoring; Heparin; Humans; International Normalized Ratio; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Platelet Function Tests; Prothrombin Time; Ticlopidine | 2008 |
19 trial(s) available for aspirin and acenocoumarol
Article | Year |
---|---|
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Humans; Injections, Subcutaneous; Middle Aged; Postoperative Complications; Thrombophlebitis; United Kingdom | 1975 |
Comparison of two levels of anticoagulant therapy in patients with substitute heart valves.
Topics: Acenocoumarol; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Thromboembolism; Time Factors | 1991 |
[A combination of dihydroergotamine and acetylsalicylic acid--prevention of postoperative thromboembolic complications. Clinical study in orthopedics].
Topics: Acenocoumarol; Adult; Aged; Aspirin; Dihydroergotamine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leg; Male; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Thromboembolism | 1987 |
[Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].
Topics: Acenocoumarol; Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Drug Evaluation; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation; Thromboembolism | 1987 |
[Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
Topics: Acenocoumarol; Adult; Ambulatory Care; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Recurrence | 1983 |
[Results of prevention of second myocardial infarct with syncumar or aspirin].
Topics: Acenocoumarol; Aged; Aspirin; Clinical Trials as Topic; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation; Random Allocation; Recurrence | 1981 |
[Adverse effects of combined use of acenocoumarol and acetylsalicylic acid after myocardial infarct and unstable angina].
Topics: Acenocoumarol; Angina, Unstable; Aspirin; Drug Synergism; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Warfarin | 1995 |
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Inst
Topics: Acenocoumarol; Anticoagulants; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Phenprocoumon; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vascular Patency | 1994 |
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Exercise Test; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Phenprocoumon; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Saphenous Vein; Thallium Radioisotopes; Treatment Outcome | 1994 |
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Ne
Topics: Acenocoumarol; Administration, Oral; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Treatment Outcome; Vascular Patency | 1993 |
[Preventive treatment of nonrheumatic atrial fibrillation: from the efficacy of clinical trials to the effectiveness of clinical practice].
Topics: Acenocoumarol; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Primary Health Care; Spain | 1997 |
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Aspirin; Female; Graft Occlusion, Vascular; Humans; Leg; Male; Phenprocoumon; Platelet Aggregation Inhibitors; Vascular Surgical Procedures | 2000 |
Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting.
Topics: Acenocoumarol; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Ticlopidine | 2000 |
Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis Implantation; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; International Normalized Ratio; Ischemia; Leg; Male; Middle Aged; Netherlands; Phenprocoumon; Treatment Outcome | 2001 |
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2007 |
Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Vitamin K | 2010 |
The effects of combined oral anticoagulant-aspirin therapy in patients undergoing tooth extractions: a prospective study.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Aspirin; Chi-Square Distribution; Dental Care for Chronically Ill; Drug Combinations; Female; Hemostatic Techniques; Humans; International Normalized Ratio; Male; Middle Aged; Oral Hemorrhage; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Tooth Extraction | 2012 |
Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
Topics: Acenocoumarol; Adult; Anticoagulants; Aspirin; Carotid Artery, Internal, Dissection; Denmark; Female; Germany; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Stroke; Switzerland; Vertebral Artery Dissection; Warfarin | 2021 |
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Hemorrhage; Humans; Ischemic Stroke; Pilot Projects; Pulmonary Embolism; Rivaroxaban; Venous Thromboembolism; Venous Thrombosis | 2023 |
33 other study(ies) available for aspirin and acenocoumarol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Blindness; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Postoperative Complications; Thromboembolism | 1976 |
Antithrombotic therapy in children and adolescents.
Topics: Acenocoumarol; Adolescent; Age Factors; Aspirin; Child; Child, Preschool; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Humans; Postoperative Complications; Sex Factors; Sexual Maturation; Thromboembolism | 1986 |
[Comparison of the prevention of thrombo-embolism by heparin and sintrom and by Macrodex and Colfarit in gynecologic surgery of the elderly (author's transl)].
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Blood Coagulation Disorders; Dextrans; Drug Therapy, Combination; Female; Germany, West; Hemorrhage; Heparin; Humans; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Pulmonary Embolism; Thromboembolism; Time Factors | 1974 |
Subdural hematoma during long-term hemodialysis.
Topics: Acenocoumarol; Adolescent; Adult; Aspirin; Cerebral Angiography; Female; Hematoma, Subdural; Heparin; Humans; Long-Term Care; Male; Phenacetin; Renal Dialysis | 1972 |
[Hemorrhagic complications in anticoagulant therapy].
Topics: Acenocoumarol; Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation; Prothrombin Time; Thrombosis | 1981 |
Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
Topics: Acenocoumarol; Adult; Aged; Aspirin; Blood Coagulation Tests; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feasibility Studies; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Prosthesis Design; Retrospective Studies; Survival Rate; Thromboembolism; Treatment Outcome | 1993 |
The risk of emergency intestinal bleeding among users of acenocoumarin: a population-based cohort study.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cohort Studies; Dipyridamole; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Intestinal Diseases; Male; Middle Aged; Prothrombin Time; Risk Factors | 1993 |
[Initial evaluation of the ACL-Futura coagulation analyzer].
Topics: Acenocoumarol; Adult; Antithrombin III; Aspirin; Bilirubin; Blood Coagulation; Blood Coagulation Tests; Child; Colorimetry; Evaluation Studies as Topic; Female; Fibrinogen; Heparin; Humans; Infant, Newborn; Lipids; Male; Nephelometry and Turbidimetry; Pregnancy; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Plasminogen Activator | 1996 |
From clinical trials to clinical practice: oral anticoagulation among patients with non-rheumatic, atrial fibrillation.
Topics: Acenocoumarol; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Contraindications; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors | 1997 |
[Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Thrombosis; Ticlopidine | 1997 |
Ischaemic stroke in young people: a prospective and long-term follow-up study.
Topics: Acenocoumarol; Adolescent; Adult; Anticoagulants; Aspirin; Brain Ischemia; Disability Evaluation; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Italy; Magnetic Resonance Angiography; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Prevalence; Prognosis; Prospective Studies; Recurrence; Risk Factors; Severity of Illness Index; Stroke; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2003 |
Coagulation monitoring and management of anticoagulation during cardiac assist device support.
Topics: Acenocoumarol; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Tests; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Heart Transplantation; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Monitoring, Physiologic; Myocardial Infarction; Risk Assessment; Severity of Illness Index; Stents; Treatment Failure; Treatment Outcome | 2003 |
Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Middle Aged; Mitral Valve Stenosis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Salicylates; Warfarin | 2004 |
[Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Analysis of the upper gastrointestinal tract bleeding prevalence in patients treated due ischaemic heart disease.
Topics: Acenocoumarol; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Body Mass Index; Clopidogrel; Female; Gastrointestinal Tract; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Ticlopidine | 2007 |
[Effect of acenocoumarol and aspirin on platelet function, markers of thrombinemia, and intracardiac thrombosis in patients with atrial fibrillation].
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Thrombocytosis; Thrombosis; Treatment Outcome | 2007 |
Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
Topics: Acenocoumarol; Administration, Topical; Aged, 80 and over; Anticoagulants; Antifungal Agents; Aspirin; Blood Coagulation Disorders; Drug Interactions; Dyspnea; Econazole; Female; Hematoma; Humans; Laryngeal Diseases; Laryngoscopy; Platelet Aggregation Inhibitors; Prothrombin | 2008 |
The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Case-Control Studies; Cytochrome P-450 CYP2C9; Drug Administration Schedule; Female; Gastrointestinal Hemorrhage; Genetic Predisposition to Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; International Normalized Ratio; Male; Mixed Function Oxygenases; Odds Ratio; Polymorphism, Genetic; Risk; Vitamin K Epoxide Reductases | 2008 |
Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K | 2008 |
The perioperative use of oral anticoagulants during surgical procedures for carpal tunnel syndrome. A preliminary study.
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Aspirin; Carpal Tunnel Syndrome; Clinical Protocols; Clinical Trials as Topic; Humans; Neurosurgical Procedures; Outcome Assessment, Health Care; Perioperative Care; Pilot Projects; Postoperative Hemorrhage; Prospective Studies; Risk Assessment; Thromboembolism | 2010 |
Invited commentary.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Phenprocoumon; Vitamin K | 2010 |
Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anticoagulants; Aspirin; Clopidogrel; Conscious Sedation; Electrocardiography; Eye Hemorrhage; Female; Humans; Male; Middle Aged; Orbit; Oximetry; Phenindione; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Ticlopidine; Vitreoretinal Surgery; Warfarin; Young Adult | 2012 |
[Ulcerated plaques of the aorta as a cause of ischaemic stroke].
Topics: Acenocoumarol; Aspirin; Echocardiography; Foramen Ovale, Patent; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Radiography; Stroke | 2012 |
Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.
Topics: Acenocoumarol; Age Factors; Antineoplastic Agents; Aspirin; Female; Genetic Predisposition to Disease; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Lenalidomide; Male; Multiple Myeloma; NF-kappa B; Polymorphism, Single Nucleotide; Protein Subunits; Pulmonary Embolism; Thalidomide; Venous Thrombosis | 2013 |
The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Coagulation; Cell Movement; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma | 2014 |
[Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Case-Control Studies; Causality; Comorbidity; Female; Humans; Hypercholesterolemia; Incidence; Macular Degeneration; Male; Population Surveillance; Prevalence; Risk Factors; Smoking; Vitamin K; Warfarin | 2015 |
Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Aortic Valve; Aspirin; Bioprosthesis; Electrocardiography; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Postoperative Complications; Practice Guidelines as Topic; Retrospective Studies; Thromboembolism | 2016 |
Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.
Topics: Acenocoumarol; Administration, Oral; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Monitoring; Drug Substitution; Epistaxis; Factor Xa Inhibitors; Female; Frail Elderly; Humans; Medication Therapy Management; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Renal Insufficiency; Rivaroxaban; Stroke | 2015 |
Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Female; Hospital Mortality; Humans; International Normalized Ratio; Male; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke; Vitamin K | 2016 |
Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Clopidogrel; Coronary Artery Disease; Enoxaparin; Female; Fibrinolytic Agents; Humans; Inappropriate Prescribing; Intracranial Hemorrhages; Lebanon; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drug Misuse; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin; Young Adult | 2016 |
Management of blunt hepatic and splenic injuries (grade ≤ III) in patients receiving antithrombotic therapy.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Aspirin; Blood Coagulation Factors; Blood Transfusion; Combined Modality Therapy; Critical Care; Disease Management; Feasibility Studies; Female; Fibrinolytic Agents; Hemorrhage; Humans; Injury Severity Score; Length of Stay; Liver; Male; Middle Aged; Plasma; Prospective Studies; Spleen; Treatment Outcome; Vitamin K; Wounds, Nonpenetrating | 2019 |